Endovascular stent graft repair of abdominal aortic aneurysms after liver transplantation

Liver Transplantation

Volumn 11, Issue 8, 2005, Pages 993-997

  Mekeel, Kristin L ^a   Lee, W Anthony ^a   Reed, Alan I ^a   Hemming, Alan W ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANASTOMOSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENDOVASCULAR SURGERY; FOLLOW UP; GRAFT REJECTION; HEMODIALYSIS; HEPATIC ARTERY; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STENT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; HUMANS; LIVER TRANSPLANTATION; MIDDLE AGED; STENTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 23744432285     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20505     Document Type: Article

References (25)

1. Piotrowski JJ, McIntyre KE, Hunter GC, Sethi GK, Bernhard VM, Copeland JC. Abdominal aortic aneurysm in the patient undergoing cardiac transplantation. J Vasc Surg 1991;14:460-467.
2. Wolters HH, Reimer P, Senniger N, Pelster F, Dietl KH. Stent graft of abdominal aortic aneurysm after renal transplantation. Ann Vasc Surg 2002;16:225-227.
3. Ballotta E, Merenda R, Mion E, Da Giau G. Abdominal aortic aneurysm in liver transplant recipients. Langenbecks Arch Surg 2001;386:426-442.
4. Testa G, Panaro F, Bogetti D, Jarzembowski T, Schuler J, Baraniewski H, Benedetti E. Simultaneous orthotopic liver and kidney transplant with repair of abdominal aortic aneurysm: operative timing. Am J Transplant 2003;3:1036-1039.
5. Hall J, Singh G, Hood D, Mateo R, Weaver F, Selby R, et al. Management of an abdominal aortic aneurysm in a patient with end stage liver disease. Am J Transplant 2004;4:666-668.
6. Englesbe MJ, Wu A, Clowes AW, Zierler RE. The prevalence and natural history of aortic aneurysms in heart and abdominal organ transplant patients. J Vasc Surg 2003;37:27-31.
7. Brophy CM, Reilly JM, Smith GJ, Tilson MD. The role of inflammation in nonspecific abdominal aortic aneurysm disease. Ann Vasc Surg 1991;3:229-233.
8. Reilly JM, Savage EB, Brophy CM, Tilson MD. Hydrocortisone rapidly induces aortic rupture in a genetically susceptible mouse. Arch Surg 1990;25:707-709.
9. Sato O, Takagi A, Miyata T, Takayama Y. Aortic aneurysms in patients with autoimmune disorders treated with corticosteroids. Eur J Vasc Endovasc Surg 1995;0:366-369.
10. Dobrin PB, Baumgartner N, Anidjar S, Chejfec G, Mrkvicka R. Inflammatory aspects of experimental aneurysms. Effect of methylprednisolone and cyclosporine. Ann NY Acad Sci 1996; 800:74-88.
11. Yamaguchi T, Masayasu Y, Mamoru S, Higashide S, Yoshimasa K, Sugiyama S, Misaki T. The effect of immunosuppression on aortic dilatation in a rat aneurysm model. Surg Today 2000;30: 1093-1099.
12. Lindholdt JS, Heickendorff L, Antonsen S, Fasting H, Henneberg EW. Natural history of abdominal aortic aneurysm with and without coexisting chronic obstructive pulmonary disease. J Vasc Surg 1998;28:226-233.
13. Nashel DJ. Is atherosclerosis a complication of long-erm corticosteroid treatment? Am J Med 1986;80:925-929.
14. Valente JF, Hricik D, Weigel K, Seaman D, Knauss T, Siegel CT, et al. Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant 2003;3:1128-1134.
15. Troppman C, Pierce JL, Gandhi MM, Gallay BJ, McVicar JP, Perez R. Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched patient pilot study. Transplantation 2003;76:426-429.
16. Dean PG, Lund WJ, Larson TS, Prieto M, Nyberg SL, Ishitani MB, et al. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 2004;77:1555-1561.
17. Fisher A, Seguel JM, de la Torre AN, Wilson D, Merchant A, Arora RK, Koneru B. Effect of sirolimus on infection incidence in liver transplant recipients. Liver Transpl 2004;10:193-198.
18. Guilbeau JM. Delayed wound healing with sirolimus after liver transplant. Ann Pharmacother 2002;36:1391-1395.
19. Neff GW, Montalbano M, Tzakis AG. Ten years of sirolimus therapy in orthotopic liver transplant recipients. Transplant Proc 2003;35:209s-216s.
20. Kim MS, Park J, Ha H, Kang SW, Jeong HJ, Kang DH, Yang CW. Rapamycin inhibits platelet-derived growth factor induced collagen, but not fibronectin, synthesis in rat mesangial cells. Yonsei Med J 2004;45:1121-1126.
21. Murphy GJ, Bricknell GR, Nicholson ML. Rapamycin inhibits vascular remodeling in an experimental model of allograft vasculopathy and attenuates associated changes in fibrosis-associated gene expression. J Heart Lung Transplant 2003;5: 533-541.
22. Matsumura JS, Brewster DG, Makaroun MS, Nattel DC. A multicenter controlled clinical trial of open versus endovascular treatment of abdominal aortic aneurysm. J Vasc Surg 2003;37:262-271.
23. Ducasse E, Calisti A, Speziale F, Rizzo L, Misuraca M, Fiorani P. Aortoiliac stent graft infection: current problems and management. Ann Vasc Surg 2004;18:521-526.
24. Karamlou T, Williamson K, Kaufman J, Wiest J. Recognition of an Infected endoluminal aortic prosthesis following repair of abdominal aortic aneurysm: case report and review of the literature. Ann Vasc Surg 2004;18:750-754.
25. Brewster DC, Cronenwett JL, Hallett JW, Johnston KW, Krupski WC, Matsumara JS. Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg 2003;37:1106-1117.